Anne B. Young Translational Neuroscience Fellowship

Massachusetts General Hospital is pleased to announce that we are accepting applications for a joint MGH/Biogen Idec training program in translational neuroscience. The two-year, clinician scientist program is open to young neurologists and psychiatrists who will receive an exceptional training experience for drug development, capitalizing on the expertise of those at Biogen Idec and Mass General. Applications from other institutions are encouraged.

The program objective is to train clinician-scientists to rapidly and efficiently translate advances in neuroscience, neuropsychiatry, and cognition into treatments for people with neurological disorders and psychiatric disease. The awardee will learn about the entire life cycle of therapy development from both industry and academic perspectives. This includes, but is not limited to, therapy selection, biomarker development, trial design, operations and regulatory science. This didactic, hands-on training program will increase the number of well-trained clinical investigators whoever passionate about drug development in the neurosciences.

Each awardee will develop a research project under the guidance of a mentoring committee that includes at least one Biogen Idec and one Mass General mentor. Awardees are expected to present their work in regular meetings and to publish results of their research in peer-review journals. Awardees will spend time at both Biogen Idec and Mass General.

The program provides annual salary support commensurate with experience plus fringe benefits. Awardees may receive additional support for course tuition, travel, computer and supplies. Additional support of clinical research projects may be available depending on the research project.

Program period: July 1, 2023– June 30, 2024
Positions available: One
Applications: Applications will be reviewed on a rolling basis with a final due date of November 1, 2022.